Northwest Biotherapeutics reported $1.51M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US USD 15.61M 1.88M
Bristol Myers Squibb BMY:US USD 299M 14M
Cti Biopharma CTIC:US USD 4M 26K
Cytori Therapeutics CYTX:US USD 173K 8K
Infinity Pharmaceuticals INFI:US USD 45K 0
Merk MRK:US USD 244M 4M
Northwest Biotherapeutics NWBO:US USD 1.51M 80K
Pfizer PFE:US USD 313M 2M
Roche Holding ROG:VX 256M 90M